CN Stock MarketDetailed Quotes

Sunshine Guojian Pharmaceutical (688336)

Watchlist
  • 71.75
  • -2.05-2.78%
Market Closed May 8 15:00 CST
44.35BMarket Cap14.91P/E (TTM)

Sunshine Guojian Pharmaceutical (688336) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
-44.37%282.57M
-57.94%193.27M
-53.20%246.11M
-39.29%369.34M
-19.11%507.97M
-50.77%459.49M
-56.47%525.85M
-43.23%608.34M
-56.26%627.97M
-14.44%933.26M
Transactional financial assets
38.00%1.19B
17.90%1.07B
30.40%1.03B
23.35%950.3M
-2.86%863.88M
50.78%910.54M
12.94%792.24M
2.74%770.38M
-8.74%889.34M
-59.37%603.87M
Notes receivable and accounts receivable
76.55%309.8M
4.55%153.84M
53.00%369.36M
17.95%219.03M
51.06%175.47M
10.43%147.14M
76.24%241.41M
17.88%185.7M
-4.39%116.16M
-10.79%133.24M
-Notes receivable
-45.76%2.48M
-10.47%3.77M
-5.24%4.29M
23.04%4.6M
29.99%4.57M
20.90%4.21M
-5.71%4.53M
2.42%3.74M
78.17%3.51M
-0.73%3.48M
-Accounts receivable
79.82%307.32M
5.00%150.07M
54.11%365.06M
17.84%214.43M
51.71%170.9M
10.15%142.93M
79.22%236.88M
18.25%181.96M
-5.76%112.65M
-11.03%129.76M
Other receivables (including interest and dividends)
-7.65%107.4K
369.99%162.29K
-28.15%345.8K
102.87%169.4K
-14.04%116.3K
-82.85%34.53K
201.53%481.3K
51.39%83.5K
-88.02%135.3K
-31.03%201.39K
-Other receivable
----
369.99%162.29K
----
102.87%169.4K
----
-82.85%34.53K
----
51.39%83.5K
----
-31.03%201.39K
Advance payment
-6.85%42.9M
3.62%38.46M
-7.49%56.02M
-28.94%30.27M
21.20%46.05M
0.82%37.12M
128.04%60.56M
58.05%42.59M
2.53%38M
53.57%36.82M
Inventories
16.16%279.63M
13.48%260.55M
19.66%243.56M
8.38%204.21M
9.94%240.73M
17.77%229.6M
12.66%203.54M
3.14%188.42M
10.91%218.97M
-14.12%194.96M
Non-current assets due within one year
111.04%748.19M
2,145.05%976.85M
929.83%444.54M
930.41%441.23M
--354.52M
--43.51M
--43.17M
--42.82M
----
----
Other current assets
280.48%3.22B
326.49%3.52B
330.05%3.45B
133.16%846.05M
145.41%846.84M
137.36%824.73M
231.94%803.15M
51.17%362.87M
2,661.29%345.08M
3,954.14%347.46M
Total current assets
100.43%6.09B
134.18%6.23B
119.44%5.86B
39.42%3.07B
35.96%3.04B
18.23%2.66B
6.99%2.67B
-9.36%2.2B
-19.58%2.24B
-24.66%2.25B
Non Current assets
Other equity investment
61.39%13.32M
67.13%13.63M
-2.83%8.46M
-14.06%8.21M
-17.37%8.25M
-10.06%8.15M
45.99%8.71M
69.07%9.55M
52.56%9.99M
43.99%9.07M
Fixed assets
----
25.38%989.6M
----
-8.49%752.85M
----
-9.71%789.29M
----
17.45%822.72M
----
23.30%874.13M
Constru in process
----
-27.42%544.11M
----
7.47%771.63M
----
8.99%749.65M
----
-7.97%717.97M
----
-4.09%687.81M
Intangible assets
43.58%317.2M
-6.79%208.75M
-6.66%212.83M
-6.55%216.87M
-6.43%220.93M
-6.74%223.96M
-6.64%228.02M
-6.53%232.06M
-6.44%236.11M
22.70%240.16M
Development expenditure
-4.60%239.65M
49.62%341.94M
104.93%296.27M
162.34%277.41M
241.67%251.2M
414.28%228.54M
38.82%144.57M
18.52%105.74M
11.53%73.52M
-61.02%44.44M
Goodwill
0.00%639.6K
0.00%639.58K
0.00%639.6K
0.00%639.6K
0.00%639.6K
0.00%639.58K
0.00%639.6K
0.00%639.6K
0.00%639.6K
0.00%639.58K
Deferred tax assets
6.85%127.83M
-2.81%125.98M
-14.54%105.78M
-1.90%129.15M
-11.05%119.64M
-11.06%129.62M
-22.28%123.79M
-22.18%131.65M
-21.97%134.5M
-15.97%145.74M
Other non current assets
-35.64%538.59M
-63.34%416.62M
-30.97%779.49M
-31.52%757.15M
-20.49%836.8M
17.77%1.14B
146.78%1.13B
113.27%1.11B
840.02%1.05B
940.27%965M
Total non current assets
-4.87%2.86B
-17.46%2.73B
-9.13%2.95B
-7.91%2.94B
-4.65%3B
8.18%3.3B
23.35%3.25B
22.47%3.2B
45.29%3.15B
44.66%3.06B
Total assets
48.11%8.95B
50.16%8.96B
48.89%8.81B
11.40%6.01B
12.21%6.04B
12.44%5.97B
15.39%5.92B
7.13%5.4B
8.84%5.38B
4.05%5.31B
Liabilities
Current liabilities
Short term loan
----
----
----
----
-0.01%50.02M
-0.01%50.02M
-0.01%50.03M
0.02%50.01M
-0.04%50.02M
-66.67%50.03M
Notes payable and accounts payable
25.46%40.7M
0.01%34.96M
7.05%46.14M
0.95%28.49M
35.74%32.44M
59.45%34.96M
111.00%43.1M
38.13%28.22M
22.07%23.9M
37.79%21.93M
-Accounts payable
25.46%40.7M
0.01%34.96M
7.05%46.14M
0.95%28.49M
35.74%32.44M
59.45%34.96M
111.00%43.1M
38.13%28.22M
22.07%23.9M
37.79%21.93M
Contract liabilities
95.62%34.12M
207.40%62.1M
21,186.58%2.61B
-68.26%6.61M
-55.85%17.44M
20.45%20.2M
-73.00%12.24M
1.57%20.84M
194.41%39.51M
-14.22%16.77M
Advance receipts
----
----
----
----
----
----
--439.57M
----
----
----
Salaries payable
-0.93%39.87M
-9.34%47.83M
1.92%45.77M
2.55%46.78M
57.58%40.24M
28.76%52.75M
32.90%44.91M
23.13%45.61M
1.79%25.54M
-9.24%40.97M
Taxs payable
70.75%10.92M
2,003.25%148.2M
37.44%7.18M
29.14%8.33M
8.46%6.39M
0.89%7.05M
-0.49%5.22M
25.36%6.45M
2.38%5.9M
-12.64%6.98M
Other payable (including interest and dividends)
0.34%151.44M
1.32%153.93M
-11.11%147.13M
-8.40%154.31M
-4.53%150.92M
-11.40%151.92M
70.11%165.52M
84.64%168.46M
84.50%158.08M
25.71%171.46M
-Dividend payable
----
----
--20.35M
----
----
----
----
----
----
----
-Other payable
----
1.32%153.93M
----
-8.40%154.31M
----
-11.40%151.92M
----
84.64%168.46M
----
25.71%171.46M
Total current liabilities
-6.86%277.05M
41.06%447.02M
275.03%2.85B
-23.49%244.52M
-1.81%297.46M
2.84%316.91M
201.65%760.6M
42.44%319.6M
51.80%302.95M
-17.85%308.14M
Current liabilities
Long term deferred income
-14.73%90.97M
-14.06%95.6M
-10.58%99.86M
-3.50%104.49M
-5.84%106.69M
-5.99%111.24M
-3.52%111.67M
-9.33%108.28M
-5.44%113.31M
-4.41%118.33M
Total non current liabilities
-14.73%90.97M
-14.06%95.6M
-10.58%99.86M
-3.50%104.49M
-5.84%106.69M
-5.99%111.24M
-3.52%111.67M
-9.33%108.28M
-5.44%113.31M
-4.41%118.33M
Total liabilities
-8.94%368.01M
26.74%542.62M
238.46%2.95B
-18.43%349.02M
-2.91%404.14M
0.39%428.15M
137.10%872.27M
24.45%427.88M
30.33%416.25M
-14.51%426.47M
Shareholders equity
Paid-in capital
0.21%618.09M
0.21%618.09M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
0.00%616.79M
Capital reserve funds
3.59%2.4B
3.32%2.39B
1.00%2.33B
0.67%2.32B
0.45%2.31B
0.30%2.31B
-0.23%2.31B
-0.31%2.3B
-0.31%2.3B
-0.27%2.3B
Surplus reserve funds
0.21%309.04M
0.21%309.04M
0.35%308.39M
0.35%308.39M
0.35%308.39M
0.35%308.39M
11.48%307.33M
11.48%307.33M
11.48%307.33M
11.48%307.33M
Retained profit
119.10%5.33B
121.13%5.15B
42.66%2.65B
38.75%2.47B
37.54%2.43B
38.88%2.33B
17.79%1.86B
17.68%1.78B
22.13%1.77B
18.58%1.68B
Other composite income
-21,630.48%-34.29M
-656.05%-13.58M
47.32%-8.4M
15.90%-9.46M
97.97%-157.8K
128.03%2.44M
-160.47%-15.95M
-103.36%-11.25M
44.40%-7.78M
18.34%-8.71M
Shareholders equity without minority interests
51.99%8.62B
51.82%8.45B
16.26%5.9B
14.15%5.7B
13.70%5.67B
13.72%5.57B
6.23%5.07B
6.07%4.99B
7.57%4.99B
6.30%4.9B
Minority interests
-18.35%-39.77M
-24.21%-38.21M
-43.23%-39.92M
-55.50%-35.33M
-68.56%-33.6M
-75.01%-30.76M
-81.68%-27.87M
-90.59%-22.72M
-115.48%-19.94M
-177.96%-17.58M
Total shareholder equity
52.19%8.58B
51.98%8.41B
16.11%5.86B
13.97%5.66B
13.47%5.64B
13.49%5.54B
5.99%5.05B
5.86%4.97B
7.36%4.97B
6.07%4.88B
Total liabilityies and equity
48.11%8.95B
50.16%8.96B
48.89%8.81B
11.40%6.01B
12.21%6.04B
12.44%5.97B
15.39%5.92B
7.13%5.4B
8.84%5.38B
4.05%5.31B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds -44.37%282.57M-57.94%193.27M-53.20%246.11M-39.29%369.34M-19.11%507.97M-50.77%459.49M-56.47%525.85M-43.23%608.34M-56.26%627.97M-14.44%933.26M
Transactional financial assets 38.00%1.19B17.90%1.07B30.40%1.03B23.35%950.3M-2.86%863.88M50.78%910.54M12.94%792.24M2.74%770.38M-8.74%889.34M-59.37%603.87M
Notes receivable and accounts receivable 76.55%309.8M4.55%153.84M53.00%369.36M17.95%219.03M51.06%175.47M10.43%147.14M76.24%241.41M17.88%185.7M-4.39%116.16M-10.79%133.24M
-Notes receivable -45.76%2.48M-10.47%3.77M-5.24%4.29M23.04%4.6M29.99%4.57M20.90%4.21M-5.71%4.53M2.42%3.74M78.17%3.51M-0.73%3.48M
-Accounts receivable 79.82%307.32M5.00%150.07M54.11%365.06M17.84%214.43M51.71%170.9M10.15%142.93M79.22%236.88M18.25%181.96M-5.76%112.65M-11.03%129.76M
Other receivables (including interest and dividends) -7.65%107.4K369.99%162.29K-28.15%345.8K102.87%169.4K-14.04%116.3K-82.85%34.53K201.53%481.3K51.39%83.5K-88.02%135.3K-31.03%201.39K
-Other receivable ----369.99%162.29K----102.87%169.4K-----82.85%34.53K----51.39%83.5K-----31.03%201.39K
Advance payment -6.85%42.9M3.62%38.46M-7.49%56.02M-28.94%30.27M21.20%46.05M0.82%37.12M128.04%60.56M58.05%42.59M2.53%38M53.57%36.82M
Inventories 16.16%279.63M13.48%260.55M19.66%243.56M8.38%204.21M9.94%240.73M17.77%229.6M12.66%203.54M3.14%188.42M10.91%218.97M-14.12%194.96M
Non-current assets due within one year 111.04%748.19M2,145.05%976.85M929.83%444.54M930.41%441.23M--354.52M--43.51M--43.17M--42.82M--------
Other current assets 280.48%3.22B326.49%3.52B330.05%3.45B133.16%846.05M145.41%846.84M137.36%824.73M231.94%803.15M51.17%362.87M2,661.29%345.08M3,954.14%347.46M
Total current assets 100.43%6.09B134.18%6.23B119.44%5.86B39.42%3.07B35.96%3.04B18.23%2.66B6.99%2.67B-9.36%2.2B-19.58%2.24B-24.66%2.25B
Non Current assets
Other equity investment 61.39%13.32M67.13%13.63M-2.83%8.46M-14.06%8.21M-17.37%8.25M-10.06%8.15M45.99%8.71M69.07%9.55M52.56%9.99M43.99%9.07M
Fixed assets ----25.38%989.6M-----8.49%752.85M-----9.71%789.29M----17.45%822.72M----23.30%874.13M
Constru in process -----27.42%544.11M----7.47%771.63M----8.99%749.65M-----7.97%717.97M-----4.09%687.81M
Intangible assets 43.58%317.2M-6.79%208.75M-6.66%212.83M-6.55%216.87M-6.43%220.93M-6.74%223.96M-6.64%228.02M-6.53%232.06M-6.44%236.11M22.70%240.16M
Development expenditure -4.60%239.65M49.62%341.94M104.93%296.27M162.34%277.41M241.67%251.2M414.28%228.54M38.82%144.57M18.52%105.74M11.53%73.52M-61.02%44.44M
Goodwill 0.00%639.6K0.00%639.58K0.00%639.6K0.00%639.6K0.00%639.6K0.00%639.58K0.00%639.6K0.00%639.6K0.00%639.6K0.00%639.58K
Deferred tax assets 6.85%127.83M-2.81%125.98M-14.54%105.78M-1.90%129.15M-11.05%119.64M-11.06%129.62M-22.28%123.79M-22.18%131.65M-21.97%134.5M-15.97%145.74M
Other non current assets -35.64%538.59M-63.34%416.62M-30.97%779.49M-31.52%757.15M-20.49%836.8M17.77%1.14B146.78%1.13B113.27%1.11B840.02%1.05B940.27%965M
Total non current assets -4.87%2.86B-17.46%2.73B-9.13%2.95B-7.91%2.94B-4.65%3B8.18%3.3B23.35%3.25B22.47%3.2B45.29%3.15B44.66%3.06B
Total assets 48.11%8.95B50.16%8.96B48.89%8.81B11.40%6.01B12.21%6.04B12.44%5.97B15.39%5.92B7.13%5.4B8.84%5.38B4.05%5.31B
Liabilities
Current liabilities
Short term loan -----------------0.01%50.02M-0.01%50.02M-0.01%50.03M0.02%50.01M-0.04%50.02M-66.67%50.03M
Notes payable and accounts payable 25.46%40.7M0.01%34.96M7.05%46.14M0.95%28.49M35.74%32.44M59.45%34.96M111.00%43.1M38.13%28.22M22.07%23.9M37.79%21.93M
-Accounts payable 25.46%40.7M0.01%34.96M7.05%46.14M0.95%28.49M35.74%32.44M59.45%34.96M111.00%43.1M38.13%28.22M22.07%23.9M37.79%21.93M
Contract liabilities 95.62%34.12M207.40%62.1M21,186.58%2.61B-68.26%6.61M-55.85%17.44M20.45%20.2M-73.00%12.24M1.57%20.84M194.41%39.51M-14.22%16.77M
Advance receipts --------------------------439.57M------------
Salaries payable -0.93%39.87M-9.34%47.83M1.92%45.77M2.55%46.78M57.58%40.24M28.76%52.75M32.90%44.91M23.13%45.61M1.79%25.54M-9.24%40.97M
Taxs payable 70.75%10.92M2,003.25%148.2M37.44%7.18M29.14%8.33M8.46%6.39M0.89%7.05M-0.49%5.22M25.36%6.45M2.38%5.9M-12.64%6.98M
Other payable (including interest and dividends) 0.34%151.44M1.32%153.93M-11.11%147.13M-8.40%154.31M-4.53%150.92M-11.40%151.92M70.11%165.52M84.64%168.46M84.50%158.08M25.71%171.46M
-Dividend payable ----------20.35M----------------------------
-Other payable ----1.32%153.93M-----8.40%154.31M-----11.40%151.92M----84.64%168.46M----25.71%171.46M
Total current liabilities -6.86%277.05M41.06%447.02M275.03%2.85B-23.49%244.52M-1.81%297.46M2.84%316.91M201.65%760.6M42.44%319.6M51.80%302.95M-17.85%308.14M
Current liabilities
Long term deferred income -14.73%90.97M-14.06%95.6M-10.58%99.86M-3.50%104.49M-5.84%106.69M-5.99%111.24M-3.52%111.67M-9.33%108.28M-5.44%113.31M-4.41%118.33M
Total non current liabilities -14.73%90.97M-14.06%95.6M-10.58%99.86M-3.50%104.49M-5.84%106.69M-5.99%111.24M-3.52%111.67M-9.33%108.28M-5.44%113.31M-4.41%118.33M
Total liabilities -8.94%368.01M26.74%542.62M238.46%2.95B-18.43%349.02M-2.91%404.14M0.39%428.15M137.10%872.27M24.45%427.88M30.33%416.25M-14.51%426.47M
Shareholders equity
Paid-in capital 0.21%618.09M0.21%618.09M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M0.00%616.79M
Capital reserve funds 3.59%2.4B3.32%2.39B1.00%2.33B0.67%2.32B0.45%2.31B0.30%2.31B-0.23%2.31B-0.31%2.3B-0.31%2.3B-0.27%2.3B
Surplus reserve funds 0.21%309.04M0.21%309.04M0.35%308.39M0.35%308.39M0.35%308.39M0.35%308.39M11.48%307.33M11.48%307.33M11.48%307.33M11.48%307.33M
Retained profit 119.10%5.33B121.13%5.15B42.66%2.65B38.75%2.47B37.54%2.43B38.88%2.33B17.79%1.86B17.68%1.78B22.13%1.77B18.58%1.68B
Other composite income -21,630.48%-34.29M-656.05%-13.58M47.32%-8.4M15.90%-9.46M97.97%-157.8K128.03%2.44M-160.47%-15.95M-103.36%-11.25M44.40%-7.78M18.34%-8.71M
Shareholders equity without minority interests 51.99%8.62B51.82%8.45B16.26%5.9B14.15%5.7B13.70%5.67B13.72%5.57B6.23%5.07B6.07%4.99B7.57%4.99B6.30%4.9B
Minority interests -18.35%-39.77M-24.21%-38.21M-43.23%-39.92M-55.50%-35.33M-68.56%-33.6M-75.01%-30.76M-81.68%-27.87M-90.59%-22.72M-115.48%-19.94M-177.96%-17.58M
Total shareholder equity 52.19%8.58B51.98%8.41B16.11%5.86B13.97%5.66B13.47%5.64B13.49%5.54B5.99%5.05B5.86%4.97B7.36%4.97B6.07%4.88B
Total liabilityies and equity 48.11%8.95B50.16%8.96B48.89%8.81B11.40%6.01B12.21%6.04B12.44%5.97B15.39%5.92B7.13%5.4B8.84%5.38B4.05%5.31B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More